Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora
Provided By PR Newswire
Last update: Jul 15, 2025
Agreement with global pharmaceutical solutions provider enhances commercial infrastructure and reinforces launch readiness for FDA-approved immunotherapy LYMPHIR™
Read more at prnewswire.comNASDAQ:CTXR (9/12/2025, 3:52:06 PM)
1.195
0 (-0.42%)
NASDAQ:CTOR (9/12/2025, 3:52:47 PM)
1.92
+0.03 (+1.59%)
Find more stocks in the Stock Screener
